Superseded public profile

Status not established↗Identity records↗

Superseded · version 1: TB-500↗

Related names recorded in this version: N-terminal acetylated 17-23 fragment of thymosin beta-4↗

A research-peptide name that FDA's substance registry maps to a thymosin beta-4 fragment.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.

What this version reported

FDA's substance registry identifies TB-500 as an N-terminal acetylated 17-23 fragment of thymosin beta-4 and explicitly states that a UNII record does not imply regulatory review or approval.↗

Organizations named in cited records:
  • U.S. Food and Drug Administration↗

Sources for this version

  1. 1
    TB-500 substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked July 29, 2026